Question

In: Statistics and Probability

2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention...

2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention of hypertension in patients with pre-hypertension (defined as systolic blood pressure between 120–139 mmHg or diastolic blood pressure between 80–89 mmHg). A total of 20 patients are randomized to receive the new drug or a currently available drug for treatment of high blood pressure. Participants are followed for up to 12 months, and time to progression to hypertension is measured. The experiences of participants in each arm of the trial are shown below.

New Drug

Currently Available Drug

Hypertension

Free of Hypertension

Hypertension

Free of Hypertension

7

8

6

8

8

8

7

9

10

8

9

11

9

10

11

11

11

12

12

12

Estimate the survival (time to progression to hypertension) functions for each treatment group using the Kaplan-Meier approach.

New Drug

Complete the table below.

Time, Months

Number at Risk

Nt

Number of Events (Hypertension)

Dt

Number Censored

Ct

Survival Probability

St+1 = St*((Nt-Dt)/Nt)

0

10

7

8

9

10

11

12

Currently Available Drug

Complete the table below.

Time, Weeks

Number at Risk

Nt

Number of Events (Hypertension)

Dt

Number Censored

Ct

Survival Probability

St+1 = St*((Nt-Dt)/Nt)

0

10

6

7

8

9

10

11

12

To answer the question as to whether or not there is a difference in time to progression, a Chi square statistic is computed. The critical value for rejection of the null hypothesis is 3.84. The computed Chi square is 0.335.

Based on comparing the computed Chi square and the critical Chi square, which of the following is (are) true?

  1. There is not statistically significant evidence to show that the time to progression is different between groups.
  2. There is statistically significant evidence to show that the time to progression is different between groups.
  3. The time to progression is essentially the same for each group.
  4. a and c.

The hazard ratio risk of progression to hypertension is 0.658. Based on this computation, which of the following is (are) true?

  1. The risk of progression to hypertension is reduced by 34.2% in patients assigned to the new drug as compared to the currently available drug.
  2. The risk of progression to hypertension is 1.52 times higher in patient’s current drug as compared to the new drug.
  3. The risk of progression to hypertension is 5.12 times higher in patient’s current drug as compared to the new drug
  4. a and b

Solutions

Expert Solution


Related Solutions

A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat type II diabetes. The efficacy of the medication will be determined by the blood glucose readings obtained from the patients. If the researcher wants a margin of error less than or equal to 5 mg/dL and the standard deviation for blood glucose readings among type II diabetics was previous documented as 15 mg/dL, how many patients should be...
Suppose a clinical trial is conducted to test the efficacy of a drug ! for treating...
Suppose a clinical trial is conducted to test the efficacy of a drug ! for treating gonorrhea in females. 100 female patients with gonorrhea are given this drug and are seen 2 weeks later, at which time 10 of the 100 patients still have gonorrhea. A.) What is the best point estimate for p, the probability of a failure with the drug A? 5% 10% 15% 20% B) What is the Standard error of the point estimate? 10% 9% 5%...
A clinical trial is run to look at the efficacy of a new blood pressure drug....
A clinical trial is run to look at the efficacy of a new blood pressure drug. Patients with a diagnosis of hypertension (high blood pressure) are recruited to participate in the trial and randomized to receive either the new drug or placebo. Participants take the assigned drug for 12 weeks and their blood pressure status is recorded. At the end of the trial, participants are classified as still having hypertension or not. The data are shown here: Group Number with...
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain...
A clinical trial is run to evaluate the efficacy of a new medication to relieve pain in patients undergoing total knee replacement surgery. In the trial, patients are randomly assigned to receive either the new medication or the standard medication. After receiving the assigned medication, patients are asked to report their pain on a scale of 0-100 with higher scores indicative of more pain. Data on the primary outcome are shown below. Sample Size Mean Pain Score Standard Deviation of...
A clinical trial is conducted comparing a new (investigational) analgesic drug to one already on the...
A clinical trial is conducted comparing a new (investigational) analgesic drug to one already on the market (Tylenol) for arthritis pain. Participants were randomly assigned to only one of the two treatment groups and the outcome was self-reported pain relief within 30 minutes. The 2 x 2 crosstab analysis with SPSS produced the following results: Chi-Square Tests Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided) Pearson Chi-Square 11.161a 1 .001 Continuity Correctionb 10.212 1 .001 Likelihood Ratio...
In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug...
In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug for treating a disease wants to investigate the effectiveness of this generic drug as compared to the traditional brand name drug, At the present time, the brand name drug is the only approved treatment for the disease. Patients diagnosed with the disease have low concentration of a specific factor in their blood. Treatment with the brand name drug will result in an increase in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 18 subjects had a mean wake time of 103.0 min. After​ treatment, the 18 subjects had a mean wake time of 78.4 min and a standard deviation of 20.7 min. Assume that the 18 sample values appear to be from a normally distributed population and construct a 95 ​% confidence interval estimate of the mean wake time for a population...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 15 subjects had a mean wake time of 105.0 min. After​ treatment, the 15 subjects had a mean wake time of 99.7 min and a standard deviation of 24.3 min. Assume that the 15 sample values appear to be from a normally distributed population and construct a 95​% confidence interval estimate of the mean wake time for a population with...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment,23 subjects had a mean wake time of 104.0 min. After​ treatment, the 23 subjects had a mean wake time of 79.5 min and a standard deviation of 23.92 min. Assume that the 23 sample values appear to be from a normally distributed population and construct a 95​% confidence interval estimate of the mean wake time for a population with drug...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 2323 subjects had a mean wake time of 100.0100.0 min. After​ treatment, the 2323 subjects had a mean wake time of 74.674.6 min and a standard deviation of 20.920.9 min. Assume that the 2323 sample values appear to be from a normally distributed population and construct a 9999​% confidence interval estimate of the mean wake time for a population with...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT